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Abstract
Background: New endovascular techniques facilitate treatment of complex deep vein obstructions in cases of
post-thrombotic syndrome. In a relevant number of these patients, endophlebectomy including the implantation of an
arteriovenous fistula between the common femoral artery and the femoral vein is indispensable in order to establish a
good inflow. These procedures display a high risk of wound complications. Despite conservative efforts to prevent these
postoperative complications, wound healing problems occur in more than 20 % of cases. The present case report is the
first description of wound dressing using a PREVENA® incision management system in cases of endophlebectomy.
Case presentation: A single center’s experience with the incision management system PREVENA®, which was used after
endophlebectomy and venous stenting in complex hybrid procedures in three white men aged 46 years, 53 years, and
61 years is the subject of this case report. Although the surgical procedures were performed under therapeutical
anticoagulation and took a couple of hours, no wound complications occurred.
Conclusions: These encouraging results underline a potential benefit of the incision management system PREVENA® in
cases of complex venous recanalization including endophlebectomy of the femoral vein as well as the implantation of
an arteriovenous fistula.
Keywords: Post-thrombotic syndrome, Endophlebectomy, Lymph fistula, Wound infection, Incision management
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Background
Impaired wound healing may be attributed to defects in
the normal tissue as response to injury and to poor wound
management. Edema, ischemia, existent systemic infec-
tion, diabetes, smoking, as well as peripheral artery disease
or venous insufficiencies are risk factors for poor wound
healing and wound complications. Furthermore, these are
associated with poor surgical outcome.
The majority of vascular surgery procedures are classi-
fied as clean surgery by the US National Research Council
because they are performed in uninfected tissue without
signs of inflammation [1]. The reported incidence of
surgical wound infections after lower limb vascular surgery
varies between 3.5 and 32 % [1–4]. Therapy for symptom-
atic chronic venous obstruction and post-thrombotic syn-
drome (PTS) has changed during the last few years.
Standard conservative treatments including anticoagula-
tion, compression therapy, and mobilization are challenged
by endovascular recanalization, partly supplemented by
open surgical reconstruction. These new methods deliver
good patency rates and an improved quality of life [5–7]. If
these post-thrombotic changes of the venous vessels, which
may involve the iliac as well as the femoral vessels,
additionally affect the common femoral vein (CFV), an
endophlebectomy has to be performed to recanalize
this segment [7, 8]; otherwise the impaired inflow
would hamper the patency of the recanalization. Fur-
thermore, the still remaining venous hypertension in
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the distal part of the lower extremity would not allow
complete improvement of complaints.
Although patients with PTS receiving interventional or
surgical treatment tend to be young and healthy, the rate
of wound complications and lymph fistula after endophle-
bectomy is high [9]. Data that address complications after
endophlebectomy are scarce [7]. Vogel et al. described
three cases with severe complications that needed add-
itional therapy due to thrombosis and hematoma after
venous surgery [6]. One of their patients had to be treated
with surgical reintervention including wound debridement
and vacuum therapy. Both pre-existing venous outflow
obstruction and arteriovenous fistula (AVF), which has to
be implanted during recanalization, increase the risk of
lymphatic leakage. The normal amount of fluid expelled
from the leg through the venous system is approximately
90 %; the amount expelled by the lymphatic system is ap-
proximately 10 %, but under post-thrombotic circum-
stances the amount can be more than 20 %.
Recent studies, which compared the outcome of an inci-
sion management system (IMS) with conventional wound
dressings in cases of groin incision, showed 20 % less
groin infections in patients with peripheral artery disease
(PAD) [10]. In contrast to negative pressure wound ther-
apy, which is established in the clinical routine and scien-
tifically evaluated in different areas of application, an IMS
has to be seen as a prophylaxis to avoid wound healing
complications [11, 12].
Animal testing with Yucatan swine revealed improved
mechanical properties and better wound conditions
after the use of an IMS in comparison with standard
care wound therapy [13]. The lateral tensile stress of
closed incisions can be decreased by approximately 50
% [14]. Correspondingly it could be shown that the rate
of hematoma and seroma of surgical incision sites can
be reduced compared with standard wound dressings in
animal testing. A reduced upregulation of genes associ-
ated with systemic inflammation, hypoxemia, and im-
paired wound healing was recognized within the first
week of use [13].
In the available literature, no case of IMS-related com-
plication such as skin lesions could be detected [15, 16].
Based on these findings, this study was established to
examine the benefit of IMS use in cases of venous recon-
struction: A reduced wound healing complication rate
should be demonstrated. Our patients are three men aged
53 years, 46 years, and 61 years who have PTS due to a
deep vein thrombosis (DVT) of the lower extremity.
Case presentation
Recanalization of obliterated femoral and iliac veins
After the standardized diagnostic work-up, including du-
plex ultrasound (DUS) and magnetic resonance venog-
raphy (MRV), the surgical procedure took place in a
dedicated intervention room or a dedicated vascular sur-
gical suite under general anesthesia. Fluoroscopic assist-
ance is necessary to enable a combined approach with
endophlebectomy of the CFV with or without AVF and
interventional disobliteration of the iliac veins [17].
The procedure starts with cannulation of the popliteal
vein in prone position or the femoral vein (FV) in supine
position under ultrasound guidance. Furthermore, an ante-
grade angiography shows the exact localization, anatomy,
and extent of the obstruction. Sometimes a retrograde
cannulation via the jugular veins is necessary to perform
the intervention. While using conventional guidewires (in-
cluding stiff wires) and catheter techniques, it is usually
possible to cross an occluded vein. After dilatation of the
involved areas of the iliac veins, self-expandable venous
stents are placed. These stents, which are provided by dif-
ferent manufacturers, have to fulfil specific demands for
the venous system. The focus on radial force and flexibility
is the main difference between arterial stents. Further dila-
tations and a venography of the obstruction level of the
FV are crucial. If the inflow is poor, an endophlebectomy
including patch reconstruction of the CFV has to be per-
formed. As a standard, a bovine patch is used. This may
include the installation of an AVF between the FV and ar-
tery by using a 6-mm ringed polytetrafluoroethylene
(PTFE) prosthesis. Due to high pressure and the experi-
ence of the performing vascular surgery department, the
use of an autologous vein should be avoided considering
the risk of pseudoaneurysm formation in this setting.
Furthermore an interventional closure of the fistula,
which usually will be performed 3 to 6 months after the
venous recanalization under local anesthesia, will be
more sophisticated. Wound closure was performed
using intracutaneous, absorbable suture material.
After the surgical procedure, which was performed
under therapeutical anticoagulation, therapy with antico-
agulants is continued for a minimum of 6 months. Low
molecular weight (LMW) heparin, phenprocoumon, or
rivaroxaban can be used. In case of phenprocoumon the
target international normalized ratio (INR) is 2.5 to 3.5.
Follow-up includes DUS examinations, clinical evalu-
ation, and, if necessary, X-ray examination of the pelvic
region to detect a dislocation or obstruction of the stent
prosthesis.
Wound therapy using an IMS (PREVENA®)
According to the instructions for use, the IMS PREVENA®
(Acelity, San Antonio, Tx, USA) allows the management
of primarily closed surgical incisions. The system includes
a dressing with an integrated drape, a foam bolster, and a
skin-contacting interface layer for ease of application.
After placement of the IMS on a closed surgical incision a
negative pressure of 125 mmHg is applied continuously to
the wound for 5 to –7 days without removal of the system
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[18]. In the cases presented in this case report, a 7-day
treatment was chosen. The acceptance of the IMS is high
due to the absence of noise during therapy and the non-
limited mobility of the patients. After 7 days, the IMS was
removed, an examination of the wound, including photo-
documentation, was performed. The same procedure was
done on the 15th and the 30th day after treatment.
Case 1
The first patient, a 53-year-old white man, with a body
mass index (BMI) of 27.5, had PTS after DVT of his
right femoral and iliac vein. His medical history included
arterial hypertension and tobacco smoking. His medica-
tion included antihypertensive drugs. After multiple sur-
gical procedures in September 2013, due to infections
related to resection of his prepatellar bursa, he devel-
oped a DVT, involving his external iliac vein (EIV) and
FV. A computed tomography (CT)-angiography and
phlebography, performed in April 2014, showed post-
thrombotic obliteration of the proximal part of his great
saphenous vein (GSV), his FV and his EIV. His common
iliac vein (CIV) and inferior vena cava (IVC) were free
of post-thrombotic changes. Despite appropriate medical
treatment with the anticoagulant rivaroxaban (Xarelto®)
and compression stockings, he had venous claudication,
severe pain, and chronic swelling of his right leg. There-
fore a recanalization of his EIV, combined with an
endophlebectomy of his CFV and an AVF from his fem-
oral artery to his CFV, was planned. The venotomy was
reconstructed with a bovine patch (see Figs. 1, 2). The
recanalization of the distal part of his CIV and EIV was
completed using two sinus–Venous stents® (12×80 mm,
14×100 mm; Optimed, Ettlingen, Germany). The oper-
ation took 663 minutes under full anticoagulation (acti-
vated clotting time 200 seconds). After the positioning
of a drain tube and wound closure, the PREVENA® IMS
was applied.
The drain tube secreted 2200 ml of mainly lymphatic
fluid and the hemoglobin dropped slightly from 14.0 to
11.9 g/dl within 72 hours. After removal of the drain
from his groin incision, the IMS remained until the sev-
enth day after surgery without any problems (see Fig. 3).
Pneumatic compression of his right leg was performed
continuously for 48 hours. Mobilization was started 48
hours after the surgical treatment. After 7 days the
PREVENA® IMS was removed without the need of re-
placement. No wound complications were observed
(see Fig. 4). An ultrasound examination showed a pa-
tent venous reconstruction.
Identical findings were collected on the 15th and the
30th day after surgery: There were no further signs of
wound complications and the reconstruction remained
patent (see Fig. 5).
Case 2
The second case was a 61-year-old white man, BMI of
28.5, who had venous claudication and severe pain in his
left leg for more than 1 year due to an old thrombosis of
his EIV. His medical history showed arterial hypertension,
dyslipidemia, and coronary heart disease. His medication
included statins, antihypertensive drugs, and aspirin. After
magnetic resonance (MR)-phlebography, which confirmed
Fig. 1 Intraoperative picture of the post-thrombotic changes of the
common femoral vein before and after endophlebectomy
Fig. 2 Picture of a venous reconstruction including venous stenting
of the iliac veins, endophlebectomy, bovine patch of the common
femoral vein, and arteriovenous fistula between the common
femoral vein and common femoral artery
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the diagnosis, the venous reconstruction was took place:
A recanalization of his EIV combined with an endophle-
bectomy of his CFV and an AVF from his femoral artery
to his CFV was realized. A bovine patch was used for the
reconstruction of the venotomy; the recanalization of the
distal part of his CIV and EIV was completed using two
sinus–Venous stents® (12×80 mm, 14×100 mm; Optimed,
Ettlingen, Germany). The operation took 320 minutes
under full anticoagulation and was finished by positioning
the drain tube and application of the PREVENA® IMS.
The drain tube secreted 450 ml of mainly lymphatic fluid;
no relevant hemoglobin decrease could be recognized.
The length of his hospital stay after venous recon-
structive surgery was 7 days and he was discharged after
removal of the IMS without any wound healing disor-
ders. In the first postoperative follow-up (15 days after
surgery), a small 0.5×0.5 cm wound healing disorder in
the median incision was observed; it was classified as
Szilagyi I°. With conservative wound dressing, the
wound healed within the next 14 days without any sub-
sequent problems (see Fig. 6).
Case 3
The third case, a 46-year-old white man, BMI of 29,
showed a history of DVT of his right leg in 1995. His
medical history showed arterial hypertension, obesity, to-
bacco smoking, dyslipidemia, and coronary heart disease.
His medication included statins, antihypertensive drugs,
and aspirin. After a failed thrombectomy within the
same year, he had venous claudication, chronic swelling,
and chronic ulceration of his lower leg for nearly 20
years. Hence he was referred to our department in 2014.
An ultrasound and MR-phlebography detected strong
venous collateralization in his abdominal area (see Fig. 7).
Treatment was performed with endophlebectomy of his
CFV and creation of an AVF, as well as venous stenting
including his EIV, his CIV, and his IVC realized by three
venous stents. Wound dressing was performed by the
use of an IMS in the operating theatre. After 7 days, the
dressing was removed and no further dressing was
Fig. 4 Wound conditions after removal of the PREVENA® incision
management system (Case 1)
Fig. 3 Postoperative application of an incision management system
(Case 1)
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necessary. During the 6-months follow-up until the
interventional closure of the AVF, no wound complica-
tions occurred.
Discussion
Although the techniques of the open surgical and the
endovascular approach of chronic venous obstruction
have developed within the last few years, the urgent
problem of wound complications, such as lymphatic fis-
tula, remains unsolved. These complications are associ-
ated with extended hospital stay, a higher rate of wound
infections, as well as pain, the use of antibiotics, surgical
re-interventions, and failure of the venous reconstruc-
tion. Moreover, the increased in-hospital costs as well as
the decreased quality of life due to an elongated stay in
hospital with long periods of immobilization as a part of
the lymph fistula treatment should be mentioned.
The recruitment of lymphatic vessels due to the venous
obliteration in patients with PTS is one cause for the
wound complications which may occur after surgical inci-
sion. In this setting, the necessity of therapeutic anticoa-
gulation contributes to the formation of a hematoma.
Furthermore, the AVF increases the venous flow and
the local pressure conditions of the venous system to
non-physiological levels. The high rate of surgical com-
plications, such as wound infections, venous recanaliza-
tion failure, and even graft infection, is challenging.
Medical treatment for weeks, chronic pain, as well as
surgical and endovascular re-interventions, may be the
consequences of wound complications related to this hy-
brid procedure.
Conclusions
The presented cases illustrate the potential benefit of an
IMS such as Prevena® after a complex venous hybrid re-
canalization including endophlebectomy of the CFV and
stent angioplasty of the femoral and iliac veins.
Fig. 6 Szilagyi I° classified wound complication 15th postoperative
day (Case 2)
Fig. 5 Wound conditions 30 days after removal of the PREVENA®
incision management system (Case 1)
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To evaluate this improved surgical site treatment with
reduced wound complication rates, further, randomized,
multicenter studies are necessary.
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Fig. 7 Incision in the right groin after venous reconstruction and
venous collateralization in the lower abdominal area can be seen.
In addition the imprint of the incision management system can be
seen around the incision (Case 3)
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